Related Experiment Videos
"Preserved" glucagon secretion in fulminant type 1 diabetes
Yuko Murase-Mishiba1, Megumi Bessho-Tachibana1, Akihisa Imagawa1
1Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Osaka, Japan.
Journal of Diabetes Investigation
|November 10, 2018
Abstract:
Mixed-meal tolerance tests were carried out after an overnight fast. Healthy control participants (■), type 1A diabetespatients (○) and fulminant type 1 diabetic patients (▲). Data are presented as the mean ± standard error of the mean.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The first epidemiological study of presymptomatic type 1 diabetes among first-degree relatives in Japan: PREP-T1D study.
Diabetes research and clinical practice·2026
Life-threatening acute complications persist among individuals with type 1 diabetes in Japan: A nationwide registry-based cross-sectional study.
Journal of diabetes investigation·2026
Noncoding RNAs as novel diagnostic biomarkers for diabetic retinopathy: A systematic review and meta-analysis.
Journal of diabetes investigation·2026
A holistic approach to type 1 diabetes: From advances in science and technology to equity in diabetes care.
Journal of diabetes investigation·2026
Role of glucagon in metabolic diseases.
Journal of diabetes investigation·2026
Accuracy, safety, and usability of a real-time continuous glucose monitoring system in pediatric diabetes management.
Journal of diabetes investigation·2026
Residual β-cell function is associated with continuous glucose monitoring metrics in patients with type 1 diabetes mellitus.
Frontiers in endocrinology·2026
Impact of Diabetes Mellitus on Wound Healing and Clinical Outcomes After Burn Injury: An Analysis Using the Burn Care Quality Platform.
Journal of burn care & research : official publication of the American Burn Association·2026
Metabolic Analysis: Tracing Gangliosides and Precursors in Foods.
Methods in molecular biology (Clifton, N.J.)·2026
Spectral characterization of advanced glycation end products in human hemoglobin, serum albumin, and erythrocytes.
Biomedical optics express·2026